The global nature of the counterfeit drugs problem means that all societies, countries, and regulatory jurisdictions are affected. Because, I remain very mindful of the impact of fake drugs in developing countries. Recently, WHO report that an estimated 1 in 10 medical products circulating in low- and middle-income countries is either substandard or falsified. Since 2013, WHO has received 1500 reports of cases of substandard or falsified products. Of these, antimalarials and antibiotics are the most commonly reported. Most of the reports (42%) come from the WHO African Region, 21% from the WHO Region of the Americas, and 21% from the WHO European Region.
Addressing the specific situation in every individual country would make for an unwieldy volume, so I have decided to take this opportunity to discuss and debate for a practical solution to fight against Counterfeit medications.
- Badges
- Science topic
- Similar topics
- Chemistry
- Pharmacology
- Pharmaceuticals
- Drugs